Digital Pathology Workflow: Breakthrough Innovation in Clinical Application

Clinical Applications

The Department of Pathology provides advanced services across Clinical, Surgical, and Molecular Pathology. KFBIO has participated in numerous clinical research projects. The company also provides reliable remote diagnostic services. KFBIO develops customized pathology systems and platforms. These solutions can integrate with Hospital Information Systems (HIS) and Laboratory Information Systems (LIS).

The company also provides high-quality AI-assisted diagnostic support for different clinical needs. KFBIO’s clinical solutions include:

• Pathological Remote Diagnosis Platform
• Pathology Information Management System
• AI Cervical Cancer Screening System

KFBIO Pathological Remote Diagnosis Platform

The KFBIO Pathological Remote Diagnosis Platform is a comprehensive solution.

It combines advanced hardware and software developed by KFBIO. The platform delivers excellent image quality and stable performance. It also ensures reliability, compatibility, and data integrity. The system is easy to operate and suitable for pathology laboratories and hospitals. KFBIO has continuously improved the platform over the years. The platform simplifies pathology workflows significantly. It enables pathologists to review slides and diagnose cases remotely. Users can access the platform without restrictions on time or location.

The system includes:

• Diagnosis management
• Frozen section management
• Case collection
• Data statistics
• Real-time multi-site collaboration

An English version is available for international users.

The platform supports:

• Remote diagnosis
• Remote consultation
• Remote frozen section services
• Pathology personnel training
• Remote expert guidance

It serves hospitals, medical alliances, third-party laboratories, and telemedicine networks. The platform is more than a diagnostic tool. It retrieves patient information from the Laboratory Information System (LIS). It also stores pathology data for future review. Patient information remains secure and private. Only authorized pathologists can access the data. The system supports multiple operating systems and devices, including:

• Windows
• Android
• IPhone
• WeChat

Remote Diagnosis Workflow

1. Hospitals submit a remote diagnosis request.
2. Digital slides are uploaded to the cloud.
3. Pathologists review cases remotely.
4. Diagnostic reports are delivered.

Pathology Information Management System

The Pathology Information Management System digitizes the entire pathology workflow. The workflow begins with specimen registration and ends with case archiving. The system tracks specimen status in real time. It also improves workflow efficiency and task handovers.

Key Features

• The platform uses a Browser/Server (B/S) architecture.
• Compared with traditional Client/Server (C/S) systems, it offers greater flexibility and easier access.
• No software installation is required.
• Users only need a web browser to access the platform.
• The system supports desktops, tablets, and mobile devices.
• Remote upgrades can be completed easily.
• KFBIO can customize interfaces and functions according to customer requirements.
• The platform connects multiple centers and different locations.

It integrates seamlessly with:

• HIS
• LIS
• PIS

Digital records comply with CNAS-CL02 (ISO 15189) standards. This helps hospitals and laboratories achieve workflow standardization. The system has been successfully deployed in multiple hospitals.

AI Cervical Cancer Screening System

The KFBIO AI Cervical Cancer Screening System is an advanced AI-assisted cytopathology solution. The platform supports pathologists during cervical cancer screening. AI algorithms automatically identify suspicious lesion areas on whole slide images. The system helps determine whether a case is positive. It also digitizes the entire pathology workflow. This improves specimen tracking and workflow management. Deep learning technology has achieved remarkable progress in recent years.AI is expected to transform healthcare and many other industries.However, many AI technologies have not yet been widely implemented in clinical practice.

KFBIO focuses on practical AI applications in digital pathology. The company applies artificial intelligence to whole slide image analysis. Its primary goal is to improve cervical cancer screening efficiency and accuracy. KFBIO is committed to advancing pathology through AI innovation.

For more information, please visit the AI-assisted screening section on the homepage.

Hardware Devices Supporting Clinical Applications

In addition to software platforms, KFBIO develops advanced hardware solutions. These solutions support digital pathology implementation in clinical environments. One of KFBIO’s key innovations is its digital pathology scanner.

KFBIO Digital Pathology Scanners

• KFBIO digital pathology scanners are among the fastest and most reliable whole slide imaging systems available.
• Powered by advanced AI technologies.
• Speed and capacity fit seamlessly into daily pathology workflows.
• Digitize a 15 mm × 15 mm slide at 20× magnification in just 25 seconds.
• Success rate reaches 99.85%.
• Support numerical apertures of 0.8 and 0.95.
• Image resolution can reach:  20× ≤ 0.25 μm/px   40× ≤ 0.125 μm/px

The touch-screen interface makes operation simple and efficient. Large batches of slides can be scanned automatically. The scanners use premium components, including:

• Olympus high-end objectives
• German industrial cameras

Digital images can be accessed through the internet. Users can view images on different devices and operating systems.

Conclusion

KFBIO is dedicated to building a complete digital pathology workflow. The company integrates digital pathology into clinical diagnosis and treatment. Its software, hardware, and service solutions are designed for real-world clinical applications. KFBIO develops solutions for every stage of the pathology process. These solutions cover specimen processing, pathology data management, and disease information management. All products are designed with usability, efficiency, and quality in mind.

KFBIO aims to expand access to digital pathology worldwide. The company strives to deliver high-performance solutions at competitive costs. Its vision is to help more people benefit from equal access to medical resources. Although challenges remain, KFBIO continues to advance toward this goal. The company remains committed to innovation and the future of digital pathology.